Found 5 matching trials
A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.
PHASE2This study will evaluate the efficacy and safety data of AZD8871 in patient...
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
PHASE2This is a study to evaluate the effects of AZD8871 in patients with COPD. A...
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects
PHASE1AZD8871 is a new chemical entity possessing long-acting dual-pharmacology (...
Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects
PHASE1This is a phase I, randomised, placebo-controlled 2-part study to assess th...
Treatments Being Tested
Dose 1, AZD8871 50 μg (Part 1)Dose 2, AZD8871 100 μg (Part 1)Dose 3, AZD8871 300 μg (Part 1)Dose 4, AZD8871 600 µg (Part 1)Dose 5, AZD8871 1200 µg (Part 1)Dose 6, AZD8871 1800 μg (Part 1)Placebo, AZD8871 placebo (Part 1)Treatment A, AZD8871 dose A (Part 2)Treatment B, AZD8871 dose B (Part 2)Treatment C, Indacaterol 150 μg (Part 2)Treatment D, Tiotropium 18 μg (Part 2) Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects
PHASE1AZD8871 is a new chemical entity possessing long-acting effect in a single ...